| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9309018 | Kidney International | 2005 | 9 Pages |
Abstract
Switching treatment with cimetidine to omeprazole in renal transplant recipients is associated with a decrease of dose/weight normalized trough levels of tacrolimus. Studies in healthy volunteers suggest that this may be explained by an increase of intestinal CYP3A4 activity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Wim P.D. Lemahieu, Bart D. Maes, Kristin Verbeke, Yves Vanrenterghem,